Characterization of Local Vascular Effects of LNMMA
Sponsor
Technische Universität Dresden (Other)
Overall Status
Completed
CT.gov ID
NCT00180063
Collaborator
(none)
1
23
Study Details
Study Description
Brief Summary
Characterization of an unexpected venodilative effect of higher L-NMMA-doses in dorsal human hand veins.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
N/A |
Study Design
Study Type:
Interventional
Allocation:
Non-Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Study Start Date
:
Oct 1, 2003
Study Completion Date
:
Sep 1, 2005
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 45 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
- healthy subjects
Exclusion Criteria:
- any relevant disease
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Institute of Clinical Pharmacology, Medical Faculty, University of Technology | Dresden | Germany | 01307 |
Sponsors and Collaborators
- Technische Universität Dresden
Investigators
- Study Chair: Wilhelm Kirch, MD, Institute of Clinical Pharmacology
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00180063
Other Study ID Numbers:
- IKPD 01-02 Amend LNMMA
First Posted:
Sep 16, 2005
Last Update Posted:
Nov 2, 2005
Last Verified:
Sep 1, 2005
Additional relevant MeSH terms: